Terkko Navigator / European Respiratory Journal

Building the house of CARDS by phenotyping on the fly.

Potential of regulatory T cell-based therapies in the management of severe COVID-19.

Using imaging to combat a pandemic: rationale for developing the UK National COVID-19 Chest Imaging Database.

Development of a Clinical Decision Support System for Severity Risk Prediction and Triage of COVID-19 Patients at Hospital Admission: an International Multicenter Study.

Challenges of evaluating lung function as part of cancer care during the COVID-19 pandemic.

SABRTOOTH: A randomised controlled feasibility study of Stereotactic Ablative Radiotherapy (SABR) with surgery in paTients with peripheral stage I nOn-small cell lung cancer (NSCLC) cOnsidered To be at Higher risk of complications from surgical resec

Cyclophilin Inhibitors Restrict Middle East Respiratory Syndrome Coronavirus Via Interferonλ In Vitro And In Mice.

Altered pulmonary capillary blood volume in childhood sickle cell disease.

Transcutaneous Carbone Dioxide Monitoring as a valid complementary method in acute respiratory failure.

COVID-19 phenotypes: leading or misleading?

Pulmonary arterial hypertension associated with primary Sjogren's syndrome: a multi-centre cohort study from China.

Vitamin C to Pregnant Smokers Persistently Improves Infant Airway Function to 12 Months of Age: A Randomised Trial.

Remote Monitoring of Oxygen Saturation in Individuals with COVID-19 Pneumonia.

Why do we still cling to spirometry for assessing small airway function?

The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision.

LAM is another small airway disease: lessons from microCT.

Assessing small airway function for early detection of lung function impairment.

Mast cells in asthma: Here I am, stuck in the middle with you.

Incidence and Significance of Venous Thromboembolism in Critically ill Pulmonary Tuberculosis Patients.

On Tuberculosis and COVID-19 co-infection.

Tailored exercise is safe and beneficial for acutely hospitalised older adults with chronic obstructive pulmonary disease.

The effect of catch-up growth in the first year of life on later wheezing phenotypes.

Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members# of ESCMID Study Group for M

COVID-19 from the land "Down Under" in an upside-down world: an Australian perspective.

Impaired pulmonary function in discharged patients with COVID-19: More work ahead.

Go slow to go fast: A plea for sustained scientific rigor in air pollution research during the COVID-19 pandemic.

A Prospective Safety and Feasibility Study of Metered CryoSpray (MCS) for Patients with Chronic Bronchitis in COPD.

Relative hyperventilation in non-ventilated patients with spinal muscular atrophy.

Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics.

Changes in treatment for multidrug-resistant tuberculosis according to national income.

Treatment options in type-2 low asthma.

Circadian asthma airway responses are gated by REV-ERBα.

Sputum neutrophil elastase in bronchiectasis: a Southern European cohort study.

A Global Respiratory Perspective on the COVID-19 Pandemic: Commentary and Action Proposals.

COVID-19 and pulmonary rehabilitation: preparing for phase three.

Progressive fibrosing interstitial lung disease: we know it behaves badly, but what does that mean?

Finding the true prevalence of obstructive lung disease: two steps forward and one step back.

Collagen IV: a critical new starting point for engineering upper airways.

α1-antitrypsin PI*SZ genotype: a SERPINA1 deficiency haplotype with uncertain clinical and therapeutic implications.

"The effect of exacerbation history on outcomes in the IMPACT trial." David M.G. Halpin, Mark T. Dransfield, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Fernando J. Martinez, Steve Pascoe, Dave Singh,

The minimal clinically important difference of the Severe Respiratory Insufficiency questionnaire in severe COPD.

Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer's disease.

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

The (in)significance of TB and COVID-19 co-infection.

Assessment of Primary Ciliary Dyskinesia Predictive Tools.

Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors (nAChR) and beyond.

Changes in respiratory symptoms during 48 weeks treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies.

Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post infection.

Thrombosis and COVID-19 pneumonia: the clot thickens!

The optimal imaging test for diagnosis of acute pulmonary embolism: a second chance for lung scintigraphy?